JHS Svendgaard Laboratories Limited (JHS.NS)
INR 22.38
(0.41%)
INR 22.38
(0.41%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 707.98 Million | 962.06 Million | 854.91 Million | 1 Billion | 1.38 Billion | 1.23 Billion |
| Cost of Revenue | 597.12 Million | 658.67 Million | 605.33 Million | 684.17 Million | 997.52 Million | 870.55 Million |
| Gross Profit | 110.85 Million | 303.39 Million | 249.58 Million | 316.54 Million | 387.43 Million | 362.11 Million |
| Operating Expenses | 183.68 Million | 469.05 Million | 299.83 Million | 279.82 Million | 415.81 Million | 375.83 Million |
| Selling, General and Administrative Expenses | 97.64 Million | 74.04 Million | 23.91 Million | 24.09 Million | 82.64 Million | 59.23 Million |
| Research and Development Expenses | - | 653 Thousand | 654 Thousand | 14 Thousand | 372 Thousand | - |
| Other Expenses | 174.46 Million | 143.97 Million | 35.17 Million | 15.78 Million | 22.5 Million | 6.94 Million |
| Cost and Expenses | 780.81 Million | 1.12 Billion | 905.16 Million | 964 Million | 1.41 Billion | 1.24 Billion |
| Operating Income | - | -69.81 Million | -41.86 Million | 3.55 Million | -29.15 Million | -31.83 Million |
| Interest Expense | 4.24 Million | 10.41 Million | 12.69 Million | 12.39 Million | 19.52 Million | 10.33 Million |
| Income Tax Expense | 6.29 Million | -50.64 Million | 43.92 Million | -3.74 Million | -9.88 Million | -3.77 Million |
| Earnings before Tax | -34.28 Million | -218.4 Million | 1.03 Million | 9.67 Million | -58.43 Million | -20.45 Million |
| Net Income | -40.57 Million | -154.63 Million | -40.52 Million | 11.98 Million | -19.79 Million | -6.8 Million |
| Earnings Per Share Basic | -0.52 | -2.38 | -0.63 | 0.20 | -0.32 | -0.11 |
| Earnings Per Share Diluted | -0.52 | -2.38 | -0.63 | 0.19 | -0.32 | -0.11 |
| Weighted Average Shares Outstanding | 78.03 Million | 64.9 Million | 64.47 Million | 61.37 Million | 60.9 Million | 60.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 78.39 Million | 64.9 Million | 64.47 Million | 61.64 Million | 60.9 Million | 60.9 Million |
| Gross Margin | 0.16 | 0.32 | 0.29 | 0.32 | 0.28 | 0.29 |
| EBIT Margin | 0.05 | 0.06 | 0.10 | 0.13 | 0.11 | 0.07 |
| Profit Margin | -0.06 | -0.16 | -0.05 | 0.01 | -0.01 | -0.01 |
| EBITDA | 33.77 Million | -163.81 Million | 28.65 Million | 94.56 Million | 46.61 Million | 60.29 Million |
| Earnings Before Tax Margin | - | -0.07 | -0.05 | 0.00 | -0.02 | -0.03 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 244.83 Million | 707.98 Million | 216.63 Million | 143 Million | 189.3 Million | 190.28 Million |
| Cost of Revenue | 188.26 Million | 597.12 Million | 190.36 Million | 117.42 Million | 107.14 Million | 127.57 Million |
| Gross Profit | 56.57 Million | 110.85 Million | 26.26 Million | 25.57 Million | 82.16 Million | 62.7 Million |
| Operating Expenses | 56.61 Million | 183.68 Million | 36.91 Million | 42.41 Million | 93.08 Million | 110.35 Million |
| Selling, General and Administrative Expenses | 56.61 Million | - | 36.91 Million | 42.41 Million | 58.69 Million | 37.29 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 3.2 Million | 43.14 Million | 13.73 Million | 23.4 Million | 1.95 Million | 13.37 Million |
| Cost and Expenses | 244.88 Million | 780.81 Million | 227.28 Million | 159.83 Million | 200.23 Million | 237.92 Million |
| Operating Income | -42 Thousand | -72.83 Million | -10.65 Million | -16.83 Million | -8.97 Million | -47.64 Million |
| Interest Expense | 1.16 Million | 4.6 Million | 1.29 Million | 1.06 Million | 963 Thousand | 2.25 Million |
| Income Tax Expense | 8.28 Million | 6.29 Million | 9.31 Million | 5.37 Million | -2.64 Million | -6.22 Million |
| Earnings before Tax | 1.99 Million | -34.28 Million | 1.79 Million | 5.49 Million | -9.93 Million | -36.53 Million |
| Net Income | -6.29 Million | -40.57 Million | -7.51 Million | 126 Thousand | -7.29 Million | -27.37 Million |
| Earnings Per Share Basic | -0.08 | - | -0.10 | 0.00 | -0.09 | -0.42 |
| Earnings Per Share Diluted | -0.08 | - | -0.10 | 0.00 | -0.09 | -0.42 |
| Weighted Average Shares Outstanding | 78.39 Million | 78.39 Million | 78.39 Million | 78.39 Million | 78.39 Million | 64.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 78.39 Million | 78.39 Million | 78.39 Million | 78.39 Million | 78.39 Million | 64.9 Million |
| Gross Margin | 0.23 | 0.16 | 0.12 | 0.18 | 0.43 | 0.33 |
| EBIT Margin | 0.08 | - | 0.04 | -0.00 | 0.03 | -0.09 |
| Profit Margin | -0.03 | -0.06 | -0.03 | 0.00 | -0.04 | -0.14 |
| EBITDA | 19.68 Million | - | 8.36 Million | -585 Thousand | 6.01 Million | -16.86 Million |
| Earnings Before Tax Margin | -0.00 | -0.10 | -0.05 | -0.12 | -0.05 | -0.25 |
ULTRACEMCO
0L3H
HUHTAMAKI
EXPLEOSOL
EVAX
TLO